Lemaitre Vascular Stock Today
| LMAT Stock | USD 84.82 0.09 0.11% |
PerformanceVery Weak
| Odds Of DistressVery Low
|
LeMaitre Vascular is selling for under 84.82 as of the 20th of March 2025; that is 0.11 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 83.96. LeMaitre Vascular has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 19th of October 2006 | Category Healthcare | Classification Health Care |
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. The company has 22.56 M outstanding shares of which 1.25 M shares are now shorted by private and institutional investors with about 6.02 trading days to cover. More on LeMaitre Vascular
Moving together with LeMaitre Stock
Moving against LeMaitre Stock
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
LeMaitre Stock Highlights
ESG Sustainability
Environmental | Governance | Social |
| Chairman and CEO | George LeMaitre | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, SP Small-Cap 600, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsLeMaitre Vascular can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand LeMaitre Vascular's financial leverage. It provides some insight into what part of LeMaitre Vascular's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LeMaitre Vascular (LMAT) is traded on NASDAQ Exchange in USA. It is located in 63 Second Avenue, Burlington, MA, United States, 01803 and employs 651 people. LeMaitre Vascular is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.92 B. LeMaitre Vascular conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 22.56 M outstanding shares of which 1.25 M shares are now shorted by private and institutional investors with about 6.02 trading days to cover.
LeMaitre Vascular currently holds about 75.68 M in cash with 44.12 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.45.
Check LeMaitre Vascular Probability Of Bankruptcy
Ownership AllocationLeMaitre Vascular maintains a total of 22.56 Million outstanding shares. The majority of LeMaitre Vascular outstanding shares are owned by institutional investors. These third-party entities are usually referred to as non-private investors looking to shop for positions in LeMaitre Vascular to benefit from reduced commissions. Accordingly, institutional holders are subject to a different set of regulations than regular investors in LeMaitre Vascular. Please pay attention to any change in the institutional holdings of LeMaitre Vascular as this could imply that something significant has changed or is about to change at the company. Also note that almost nine hundred ninety-nine thousand three hundred fourty-six invesors are currently shorting LeMaitre Vascular expressing very little confidence in its future performance.
Check LeMaitre Ownership Details
LeMaitre Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Northern Trust Corp | 2024-12-31 | 327.8 K | |
| T. Rowe Price Associates, Inc. | 2024-12-31 | 284.8 K | |
| Driehaus Capital Management Llc | 2024-12-31 | 263.2 K | |
| Envestnet Asset Management Inc | 2024-12-31 | 259.4 K | |
| Acadian Asset Management Llc | 2024-12-31 | 236.8 K | |
| Rice Hall James & Associates, Llc | 2024-12-31 | 235.1 K | |
| Goldman Sachs Group Inc | 2024-12-31 | 206.6 K | |
| Charles Schwab Investment Management Inc | 2024-12-31 | 195.8 K | |
| Kayne Anderson Rudnick Investment Management Llc | 2024-12-31 | 193.1 K | |
| Blackrock Inc | 2024-12-31 | 3.9 M | |
| Conestoga Capital Advisors, Llc | 2024-12-31 | 1.7 M |
LeMaitre Vascular Historical Income Statement
LeMaitre Stock Against Markets
LeMaitre Vascular Corporate Executives
Elected by the shareholders, the LeMaitre Vascular's board of directors comprises two types of representatives: LeMaitre Vascular inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LeMaitre. The board's role is to monitor LeMaitre Vascular's management team and ensure that shareholders' interests are well served. LeMaitre Vascular's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LeMaitre Vascular's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Pellegrino | CFO, Principal Accounting Officer and Secretary | Profile |
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.